Wealth Enhancement Advisory Services, LLC Repligen Corp Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Repligen Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 4,354 shares of RGEN stock, worth $663,418. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,354
Previous 4,001
8.82%
Holding current value
$663,418
Previous $534,000
24.16%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding RGEN
# of Institutions
529Shares Held
59.2MCall Options Held
321KPut Options Held
667K-
Black Rock Inc. New York, NY7.57MShares$1.15 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$769 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.51MShares$534 Million0.05% of portfolio
-
United Capital Financial Advisers, LLC Newport Beach, CA2.76MShares$420 Million2.74% of portfolio
-
State Street Corp Boston, MA1.8MShares$275 Million0.01% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.46B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....